Immunai
immunai.comLocations
New York, NY, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series B
founded in
2019
Immunai is the first platform company that maps the entire immune system by combining cutting-edge engineering &AI with high-throughput single-cell omics, and accelerates the drug development process.
Something looks off?Open jobs at Immunai